23 days ago
Chinese drug Loberamisal extends stroke treatment window from 6 hours to 2 days
What's happening
SignalsMonitor is following this as a general story. South China Morning Post Asia is the outlet attached so far. The first report grouped here was at 24 Sept 2026, 06:29 UTC. The headline in use is “Chinese drug Loberamisal extends stroke treatment window from 6 hours to 2 days”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
Chinese medical scientists have shattered the brief window of time available to limit stroke damage, effectively shielding injured brain cells and dramatically improving the odds of a full recovery. Brain cells start dying within minutes of a clot blocking an artery, leading to facial droop, affected speech and in severe…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by South China Morning Post Asia
Chinese drug loberamisal extends stroke treatment window from 6 hours to 2 days
Reported by 1 outlet
- South China Morning Post
- South China Morning PostChinese drug loberamisal extends stroke treatment window from 6 hours to 2 days